BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27256228)

  • 1. [Rapamycin in the treatment of cardiac rhabdomyoma associated with tuberous sclerosis complex].
    Pang LY; Zou LP; Huang LL; Gao Y; Ma SF; Zhang MN; Wang YY
    Zhonghua Er Ke Za Zhi; 2016 Jun; 54(6):424-7. PubMed ID: 27256228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of symptomatic multiple cardiac rhabdomyomas associated with tuberous sclerosis complex in a newborn receiving everolimus.
    Doğan V; Yeşil Ş; Kayalı Ş; Beken S; Özgür S; Ertuğrul İ; Bozkurt C; Örün UA; Karademir S
    J Trop Pediatr; 2015 Feb; 61(1):74-7. PubMed ID: 25344617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus Can Increase the Disappearance Rate of Cardiac Rhabdomyomas Associated with Tuberous Sclerosis: A Prospective Cohort and Self-Controlled Case Series Study.
    Chen XQ; Wang YY; Zhang MN; Lu Q; Pang LY; Liu LY; Li YF; Zou LP
    J Pediatr; 2021 Jun; 233():150-155.e4. PubMed ID: 33631166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid response of a cardiac rhabdomyoma causing severe right ventricular outflow obstruction to Sirolimus in an infant with negative genetics for Tuberous sclerosis.
    Nir-David Y; Brosilow S; Khoury A
    Cardiol Young; 2021 Feb; 31(2):312-314. PubMed ID: 33148352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid regression of large cardiac rhabdomyomas in neonates after sirolimus therapy.
    Weiland MD; Bonello K; Hill KD
    Cardiol Young; 2018 Mar; 28(3):485-489. PubMed ID: 29233209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal Tuberous Sclerosis: Sirolimus for the Treatment of Fetal rhabdomyoma.
    Dagge A; Silva LA; Jorge S; Nogueira E; Rebelo M; Pinto L
    Fetal Pediatr Pathol; 2022 Oct; 41(5):800-806. PubMed ID: 34281475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rapamycin in the treatment of renal diseases associated with tuberous sclerosis complex].
    Dun S; Zou LP; Zhang MN; Wang YY; He W; Chen HM; Hu LY; Chen XQ; Lu Q; Pang LY; Liu LY; Tang LN; Wang B
    Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):852-856. PubMed ID: 31665839
    [No Abstract]   [Full Text] [Related]  

  • 8. Regression of a cardiac rhabdomyoma in a patient receiving everolimus.
    Tiberio D; Franz DN; Phillips JR
    Pediatrics; 2011 May; 127(5):e1335-7. PubMed ID: 21464184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everolimus for severe arrhythmias in tuberous sclerosis complex related cardiac rhabdomyomas.
    Silva-Sánchez MP; Alvarado-Socarras JL; Castro-Monsalve J; Meneses KM; Santiago J; Prada CE
    Am J Med Genet A; 2021 May; 185(5):1525-1531. PubMed ID: 33590972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac rhabdomyomas: clinical progression, efficacy and safety of everolimus treatment.
    Yıldırım S; Aypar E; Aydın B; Akyüz C; Aykan HH; Ertuğrul İ; Karagöz T; Alehan D
    Turk J Pediatr; 2023; 65(3):479-488. PubMed ID: 37395967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated Cardiac Rhabdomyoma Regression with Everolimus in Infants with Tuberous Sclerosis Complex.
    Aw F; Goyer I; Raboisson MJ; Boutin C; Major P; Dahdah N
    Pediatr Cardiol; 2017 Feb; 38(2):394-400. PubMed ID: 27878332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Everolimus for cardiac rhabdomyomas in children with tuberous sclerosis. The ORACLE study protocol (everOlimus for caRdiac rhAbdomyomas in tuberous sCLErosis): a randomised, multicentre, placebo-controlled, double-blind phase II trial.
    Stelmaszewski EV; Parente DB; Farina A; Stein A; Gutierrez A; Raquelo-Menegassio AF; Manterola C; de Sousa CF; Victor C; Maki D; Morón EM; de Abrantes FF; Iqbal F; Camacho-Vilchez J; Jimenez-Pavón J; Polania JP; Thompson L; Bonanato L; Diebold M; Da Silva MVCP; Nashwan MWJ; Galvani MAG; Idris OEA; Danos P; Ortiz-Lopez R; Mahmoud RAA; Gresse S; Loss KL
    Cardiol Young; 2020 Mar; 30(3):337-345. PubMed ID: 31983379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study.
    Ebrahimi-Fakhari D; Mann LL; Poryo M; Graf N; von Kries R; Heinrich B; Ebrahimi-Fakhari D; Flotats-Bastardas M; Gortner L; Zemlin M; Meyer S
    Orphanet J Rare Dis; 2018 Jul; 13(1):117. PubMed ID: 30016967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal Sirolimus Treatment for Rhabdomyomas in Tuberous Sclerosis.
    Ebrahimi-Fakhari D; Stires G; Hahn E; Krueger D; Franz DN
    Pediatr Neurol; 2021 Dec; 125():26-31. PubMed ID: 34624607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Everolimus for the Treatment of Tuberous Sclerosis Complex-Related Cardiac Rhabdomyomas in Pediatric Patients.
    Dahdah N
    J Pediatr; 2017 Nov; 190():21-26.e7. PubMed ID: 28888564
    [No Abstract]   [Full Text] [Related]  

  • 16. Neonatal rhabdomyoma with cardiac dysfunction: favourable response to sirolimus.
    Duan M; Sundararaghavan S; Koh AL; Soh SY
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35332001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Rhabdomyomas in Tuberous Sclerosis Complex.
    Castro-Monsalve J; Alvarado-Socarras JL; Mantilla KA; Forero L; Moreno A; Prada CE
    J Pediatr; 2018 Jan; 192():264-264.e1. PubMed ID: 29128117
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study.
    Saffari A; Brösse I; Wiemer-Kruel A; Wilken B; Kreuzaler P; Hahn A; Bernhard MK; van Tilburg CM; Hoffmann GF; Gorenflo M; Hethey S; Kaiser O; Kölker S; Wagner R; Witt O; Merkenschlager A; Möckel A; Roser T; Schlump JU; Serfling A; Spiegler J; Milde T; Ziegler A; Syrbe S
    Orphanet J Rare Dis; 2019 May; 14(1):96. PubMed ID: 31053163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Rhabdomyomas Presenting with Critical Cardiac Obstruction in Neonates and Infants: Treatment Strategies and Outcome, A Single-Center Experience.
    Ng LY; McGuinness J; Prendiville T; Franklin O; Walsh M; Kenny D; Nolke L; McMahon CJ
    Pediatr Cardiol; 2024 Jun; 45(5):1132-1141. PubMed ID: 38480570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Literature review of international mammalian target of rapamycin inhibitor use in the non-surgical management of haemodynamically significant cardiac rhabdomyomas.
    Cleary A; McMahon CJ
    Cardiol Young; 2020 Jul; 30(7):923-933. PubMed ID: 32524929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.